JP2010523596A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523596A5
JP2010523596A5 JP2010502341A JP2010502341A JP2010523596A5 JP 2010523596 A5 JP2010523596 A5 JP 2010523596A5 JP 2010502341 A JP2010502341 A JP 2010502341A JP 2010502341 A JP2010502341 A JP 2010502341A JP 2010523596 A5 JP2010523596 A5 JP 2010523596A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
alkylenyl
conr
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010502341A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523596A (ja
JP5347164B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/059505 external-priority patent/WO2008124651A2/en
Publication of JP2010523596A publication Critical patent/JP2010523596A/ja
Publication of JP2010523596A5 publication Critical patent/JP2010523596A5/ja
Application granted granted Critical
Publication of JP5347164B2 publication Critical patent/JP5347164B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010502341A 2007-04-05 2008-04-04 ニトロ−イミダゾール低酸素造影剤 Expired - Fee Related JP5347164B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92193207P 2007-04-05 2007-04-05
US60/921,932 2007-04-05
US96425407P 2007-08-10 2007-08-10
US60/964,254 2007-08-10
PCT/US2008/059505 WO2008124651A2 (en) 2007-04-05 2008-04-04 Nitro-imidazole hypoxia imaging agents

Publications (3)

Publication Number Publication Date
JP2010523596A JP2010523596A (ja) 2010-07-15
JP2010523596A5 true JP2010523596A5 (enExample) 2011-05-12
JP5347164B2 JP5347164B2 (ja) 2013-11-20

Family

ID=39831553

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010502341A Expired - Fee Related JP5347164B2 (ja) 2007-04-05 2008-04-04 ニトロ−イミダゾール低酸素造影剤

Country Status (7)

Country Link
US (2) US7807394B2 (enExample)
EP (1) EP2132200B1 (enExample)
JP (1) JP5347164B2 (enExample)
KR (1) KR101523257B1 (enExample)
CN (1) CN101652360B (enExample)
CA (1) CA2683433C (enExample)
WO (1) WO2008124651A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101523257B1 (ko) * 2007-04-05 2015-05-27 쓰레솔드 파마슈티컬스, 인코포레이티드 니트로-이미다졸 저산소증 영상화제
CN101709060B (zh) * 2009-12-02 2013-05-01 北京师范大学 一种f-三唑环-聚乙二醇-甲硝唑化合物及其制备方法
AU2011213568B2 (en) 2010-02-08 2016-05-12 Lantheus Medical Imaging, Inc. Methods and apparatus for synthesizing imaging agents, and intermediates thereof
US9023316B2 (en) 2010-04-08 2015-05-05 Siemens Medical Solutions Usa, Inc. Synthesis of 18F-labeled tracers in hydrous organic solvents
US10639608B2 (en) 2010-04-08 2020-05-05 Siemens Medical Solutions Usa, Inc. System, device and method for preparing tracers and transferring materials during radiosynthesis
CN101921263A (zh) * 2010-04-16 2010-12-22 兰州大学 2-硝基咪唑衍生物及其用途和制备方法
CN106977429B (zh) 2010-05-11 2021-08-24 蓝瑟斯医学影像公司 用于合成和使用造影剂的组合物、方法和系统
DK2753605T3 (da) 2011-09-09 2019-06-17 Lantheus Medical Imaging Inc Sammensætninger, fremgangsmåder, og systemer til syntesen og anvendelsen af billeddannelsesmidler
US9061143B2 (en) 2011-10-14 2015-06-23 Sumitomo Heavy Industries, Ltd. Charged particle beam irradiation system and charged particle beam irradiation planning method
EP2793871A4 (en) * 2011-12-23 2015-07-22 Auckland Uniservices Ltd COMPOUNDS AND METHODS FOR SELECTIVE IMAGING AND / OR ABLATION
WO2014062856A1 (en) 2012-10-16 2014-04-24 Halozyme, Inc. Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
ES2580334T3 (es) 2014-01-13 2016-08-23 Yang, Guanghua Composiciones de dendrímeros, métodos de síntesis, y sus usos
KR20170058360A (ko) * 2014-09-25 2017-05-26 니혼 메디피직스 가부시키가이샤 신장 이미징제
WO2016179117A1 (en) * 2015-05-01 2016-11-10 Vanderbilt University Composition and method for detecting hypoxia
US10695450B2 (en) 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
CN106977501A (zh) * 2017-03-20 2017-07-25 华东师范大学 一种基于2‑硝基咪唑‑1‑烷基醇的低氧激活前药
FR3068695B1 (fr) * 2017-07-05 2019-08-16 Centre National De La Recherche Scientifique Composes utiles comme agent d'imagerie de l'hypoxie
CA3076256A1 (en) * 2017-09-19 2019-03-28 The Governors Of The University Of Alberta Markers, conjugates, compositions and methods for hypoxia imaging, mapping, and therapy
WO2019056098A1 (en) * 2017-09-19 2019-03-28 The Governors Of The University Of Alberta BIOREDUCTION-ACTIVATED COMPOUNDS, THEIR PRODRUGS, RADIOPHARMACEUTICAL PRODUCTS, COMPOSITIONS AND THEIR APPLICATIONS IN THE MULTIMODAL THERANOSTIC MANAGEMENT OF HYPOXIA, INCLUDING CANCER
WO2021138540A1 (en) 2020-01-03 2021-07-08 Berg Llc Polycyclic amides as ube2k modulators for treating cancer
CN111233821B (zh) * 2020-01-20 2022-12-27 上海交通大学医学院附属仁济医院 含3-羟基苯甲酸基团的新抗霉素衍生物及其制备方法和应用
CN114478489B (zh) * 2022-01-18 2023-04-28 中国科学院精密测量科学与技术创新研究院 一种氟-19修饰的硝基咪唑化合物及其衍生物的制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674693A (en) * 1994-03-18 1997-10-07 Natural Pharmacia International Inc. Derivatives of 2-nitro-imidazoles as hypoxic cell markers
US5721265A (en) * 1994-08-05 1998-02-24 Sri International Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells
ATE302175T1 (de) * 1999-08-11 2005-09-15 Univ Catholique Louvain Verfahren zur herstellung von (18f) radiomarkierten nitroimidazol-derivaten zum nachweis zellulärer hypoxie
KR101523257B1 (ko) * 2007-04-05 2015-05-27 쓰레솔드 파마슈티컬스, 인코포레이티드 니트로-이미다졸 저산소증 영상화제

Similar Documents

Publication Publication Date Title
JP2009541403A5 (enExample)
JP2010506991A5 (enExample)
JP2010504301A5 (enExample)
JP2010501534A5 (enExample)
JP2010538767A5 (enExample)
JP2011506530A5 (enExample)
HRP20140667T4 (hr) Nukleozid fosforamidat prolijekovi
JP2011134884A5 (enExample)
JP2009539914A5 (enExample)
JP2009529091A5 (enExample)
JP2008515616A5 (enExample)
JP2011526312A5 (enExample)
JP2011168603A5 (enExample)
JP2010505027A5 (enExample)
JP2011508438A5 (enExample)
JP2010524750A5 (enExample)
JP2009542225A5 (enExample)
JP2013500200A5 (enExample)
JP2013527474A5 (enExample)
NL300871I2 (nl) ixazomib en farmaceutisch aanvaardbare zouten en esters daarvan, zoals ixazomibcitraat
JP2010529364A5 (enExample)
JP2010285401A5 (enExample)
JP2011016798A5 (enExample)
JP2009075520A5 (enExample)
JP2009055850A5 (enExample)